Incorporated in 1995, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations in various acute and chronic therapeutic areas and several consumer healthcare products.
Financial Results:
Mankind Pharma Ltd reported Revenues for Q2FY25 of ₹2,530.00 Crores up from ₹2,260.00 Crore year on year, a rise of 11.95%.
Total Expenses for Q2FY25 of ₹1,865.00 Crores up from ₹1,743.00 Crores year on year, a rise of 7.0%.
Consolidated Net Profit of ₹634.00 Crores up 34.04% from ₹473.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹15.84, up 34.24% from ₹11.80 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.